Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 13;11(1):871.
doi: 10.1038/s41598-020-79387-8.

Serum carotenoids and Pediatric Metabolic Index predict insulin sensitivity in Mexican American children

Affiliations

Serum carotenoids and Pediatric Metabolic Index predict insulin sensitivity in Mexican American children

Srinivas Mummidi et al. Sci Rep. .

Abstract

High concentrations of carotenoids are protective against cardiometabolic risk traits (CMTs) in adults and children. We recently showed in non-diabetic Mexican American (MA) children that serum α-carotene and β-carotene are inversely correlated with obesity measures and triglycerides and positively with HDL cholesterol and that they were under strong genetic influences. Additionally, we previously described a Pediatric Metabolic Index (PMI) that helps in the identification of children who are at risk for cardiometabolic diseases. Here, we quantified serum lycopene and β-cryptoxanthin concentrations in approximately 580 children from MA families using an ultraperformance liquid chromatography-photodiode array and determined their heritabilities and correlations with CMTs. Using response surface methodology (RSM), we determined two-way interactions of carotenoids and PMI on Matsuda insulin sensitivity index (ISI). The concentrations of lycopene and β-cryptoxanthin were highly heritable [h2 = 0.98, P = 7 × 10-18 and h2 = 0.58, P = 1 × 10-7]. We found significant (P ≤ 0.05) negative phenotypic correlations between β-cryptoxanthin and five CMTs: body mass index (- 0.22), waist circumference (- 0.25), triglycerides (- 0.18), fat mass (- 0.23), fasting glucose (- 0.09), and positive correlations with HDL cholesterol (0.29). In contrast, lycopene only showed a significant negative correlation with fasting glucose (- 0.08) and a positive correlation with HDL cholesterol (0.18). Importantly, we found that common genetic influences significantly contributed to the observed phenotypic correlations. RSM showed that increased serum concentrations of α- and β-carotenoids rather than that of β-cryptoxanthin or lycopene had maximal effects on ISI. In summary, our findings suggest that the serum carotenoids are under strong additive genetic influences and may have differential effects on susceptibility to CMTs in children.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Genetic correlation coefficients (ρG) from α-carotene (A), β-carotene (B), β-cryptoxanthin (C), and lycopene (D) and their correlation with CMTs. The solid dots show the estimated rho coefficient; bars correspond to 95% confidence intervals, and the dotted vertical line corresponds to the absence of correlation (ρG = 0). Both carotenoids show a positive correlation with HDL-C. Several obesity-related traits showed a negative correlation with β-carotene and β-cryptoxanthin. If the FDR correction is applied, the significant P-value threshold is < 0.02 (corresponding to a nominal P-value < 0.05). For simplicity, the data for SBP and DBP are not shown.
Figure 2
Figure 2
Response surface contour plots showing the relationship of α-carotene (A), β-carotene (B), β-cryptoxanthin (C), and lycopene (D) and PMI with Matsuda ISI. The contour plots are colored to aid in better visualization of the graphics.

References

    1. Ogden CL, C. M., Fryar CD, Flegal KM. in N.C.H.S. data brief, no 219 (ed National Center for Health Statistics) (Hyattsville, Maryland, 2015).
    1. Estrada E, et al. Children’s Hospital Association consensus statements for comorbidities of childhood obesity. Child Obes. 2014;10:304–317. doi: 10.1089/chi.2013.0120. - DOI - PMC - PubMed
    1. Gungor NK. Overweight and obesity in children and adolescents. J. Clin. Res. Pediatr. Endocrinol. 2014;6:129–143. doi: 10.4274/Jcrpe.1471. - DOI - PMC - PubMed
    1. Herouvi D, Karanasios E, Karayianni C, Karavanaki K. Cardiovascular disease in childhood: The role of obesity. Eur. J. Pediatr. 2013;172:721–732. doi: 10.1007/s00431-013-1932-8. - DOI - PubMed
    1. Poyrazoglu S, Bas F, Darendeliler F. Metabolic syndrome in young people. Curr. Opin. Endocrinol. Diabetes Obes. 2014;21:56–63. doi: 10.1097/01.med.0000436414.90240.2c. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources